Shahrbano Rostami on Muck Rack

Shahrbano Rostami

As seen in: Nature, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shahrbano

Contact Shahrbano, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia - Scientific Reports

|
By Majid Safa, Shahrbano Rostami, Ashkan Shabannezhad, Nasrin Alizadghandforoush, Bahram Chahardouli
| Nature Verified
Abstract Chronic myeloid leukemia (CML) is a clonal neoplasm originating from hematopoietic stem cells which is characterized by t(9;22)(q34;q11.2) fusion gene leading to forming an oncoprotein. miR-411 and SPRY4 may influence CML leukemogenesis by regulating proliferation, differentiation, and various signaling pathways induced by the oncoprotein.
Open in Who Shared Issue with article?

Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia

|
By Zohreh Sharifi, Mohammad Faranoush, Alireza Mohseni, Shahrbano Rostami
| Future Medicine Verified
Metrics Downloaded 0 times History Received 21 July 2018 Accepted 2 July 2019 Published online 24 October 2019 Information © 2019 Future Medicine Ltd KeywordsFinancial & competing interests disclosure This work was supported by Iranian Blood Transfusion Organization (IBTO).
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified